| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K.
Amino acid residues 288 to 302 of the fusion protein of measles virus were predicted by a variety of methods to represent a putative T cell epitope. This sequence was synthesized and the peptide was injected into mice of six inbred strains to test this possibility. Lymphocytes from peptide-immunized mice from all six H-2 disparate strains were able to mount a proliferative response following in vitro culture with the peptide. In addition, lymphocytes from three strains also proliferated in the presence of live measles virus. The peptide also behaved as a B cell epitope in that immunization with free peptide in adjuvant resulted in anti-peptide antibody production in all mouse strains. However, these antibodies did not react with the virus in either a solid-phase immunoassay or a virus neutralization assay. Peripheral blood lymphocytes from 10 laboratory personnel with a prior history of exposure to measles virus were tested in a proliferation assay with the peptide and with the virus. Lymphocytes from all 10 individuals proliferated in response to culture with the virus and those from eight responded to the peptide. These results give further support to the concept of permissive interaction of antigenic peptides with a wide range of class II major histocompatibility complex molecules both in mice and man and indicate the possibility of designing peptides that could be used as components of a synthetic vaccine for use in man.
Received 22 March 1990;
accepted 31 May 1990.
This article has been cited by other articles:
|
|
 |
|
  I. G. Ovsyannikova, K. L. Johnson, D. C. Muddiman, R. A. Vierkant, and G. A. Poland Identification and Characterization of Novel, Naturally Processed Measles Virus Class II HLA-DRB1 Peptides J. Virol., January 1, 2004; 78(1): 42 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Dakappagari, J. Pyles, R. Parihar, W. E. Carson, D. C. Young, and P. T. P. Kaumaya A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses J. Immunol., April 15, 2003; 170(8): 4242 - 4253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Woelk, O. G. Pybus, L. Jin, D. W. G. Brown, and E. C. Holmes Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections J. Gen. Virol., June 1, 2002; 83(6): 1419 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Welter, J. Taylor, J. Tartaglia, E. Paoletti, and C. B. Stephensen Vaccination against Canine Distemper Virus Infection in Infant Ferrets with and without Maternal Antibody Protection, Using Recombinant Attenuated Poxvirus Vaccines J. Virol., July 15, 2000; 74(14): 6358 - 6367. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. K. Dakappagari, D. B. Douglas, P. L. Triozzi, V. C. Stevens, and P. T. P. Kaumaya Prevention of Mammary Tumors with a Chimeric HER-2 B-cell Epitope Peptide Vaccine Cancer Res., July 1, 2000; 60(14): 3782 - 3789. [Abstract] [Full Text]
|
|
|
|
|
|
K. C. El Kasmi, S. Fillon, D. M. Theisen, H. Hartter, N. H. C. Brons, and C. P. Muller Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies J. Gen. Virol., March 1, 2000; 81(3): 729 - 735. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. C. Webb and A. W. Cripps A P5 Peptide That Is Homologous to Peptide 10 of OprF from Pseudomonas aeruginosa Enhances Clearance of Nontypeable Haemophilus influenzae from Acutely Infected Rat Lung in the Absence of Detectable Peptide-Specific Antibody Infect. Immun., January 1, 2000; 68(1): 377 - 381. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
